BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

MolecularMD 

2611 SW 3rd Avenue

Portland  Oregon  97201  U.S.A.
Phone: 888-663-7382 Fax: 503-459-4976


SEARCH JOBS




Industry
Diagnostics






 Company News
MolecularMD Cambridge Laboratory Receives CAP Accreditation With Focus On NGS Panels For Clinical Trial Enrollment And NGS Liquid Biopsy Testing 12/18/2014 11:21:03 AM
MolecularMD Develops Notch1 Next Generation Sequencing Test To Support Clinical Development For OncoMed Pharmaceuticals, Inc. (OMED)'s Anti-Notch1 Antibody, OMP-52M51 6/12/2014 10:08:39 AM
MolecularMD Receives CLIA Certification For Its Second Next Generation Sequencing Laboratory 4/7/2014 10:37:31 AM
MolecularMD Launches NanoString Platform For Multiplexed Digital Evaluation Of Gene Expression And Copy Number Variation In Clinical Specimens 3/6/2014 9:19:33 AM
MolecularMD To Develop Highly Sensitive Companion Diagnostic Test To Support CML Treatment Free Remission Clinical Trials 2/19/2014 10:16:10 AM
MolecularMD Announces Presentations at Upcoming American Society of Hematology Annual Meeting 12/5/2013 9:52:01 AM
Personal Genome Diagnostics and MolecularMD Collaborate to Provide Advanced Genomic Testing Services to Cancer Drug Developers 10/25/2013 10:01:42 AM
MolecularMD Obtains License to Commercialize Predictive Diagnostic Based on Actionable Biomarker, DDR2, for Uses in Lung Cancer and Targeted Kinase Therapy 7/29/2013 9:42:00 AM
MolecularMD Obtains Exclusive License to Uses of FGFR2 Activating Mutations in Endometrial Cancer 5/30/2013 11:02:09 AM
MolecularMD Offers Testing Services for Determining LKB1 Mutation and Expression Status 4/9/2013 12:18:31 PM
123